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ABSTRACT

STATISTICAL PARAMETRIC MAPPING ANALYSIS OF POSITRON EMISSION
TOMOGRAPHY IMAGES FOR THE DETECTION OF SEIZURE FOCI: RESULTS IN
TEMPORAL LOBE EPILEPSY. Jeffrey R. Tseng, Rajesh Krishnamurthy, Douglas
Bremner, Susan S. Spencer, Dennis D. Spencer, Holley M. Dey. Section of Nuclear
Medicine, Department of Diagnostic Radiology, Yale University, School of Medicine, New
Haven, CT.
The puipose of this study was to determine the efficacy of statistical parametric
mapping (SPM) of [18F]-fluoro-2-deoxyglucose (FDG) positron emission tomography
(PET) images of the brain for the localization of seizure foci in patients with temporal lobe
epilepsy (TLE).
Preoperative PET brain scans from 36 patients with TLE and from 8 healthy control
subjects were retrospectively analyzed with SPM95 software written for Matlab version
4.2. Scans were transformed to Talairach space, globally normalized, and smoothed.
Differences between each patient’s scan and the control group were then computed with the
t statistic on a voxel by voxel basis. SPM maps were thresholded at p < 0.001 and
reviewed for areas of significant hypometabolism relative to the control group. All 44
clinical 18FDG brain scans were also visually interpreted and regions of metabolic
asymmetry noted. Localization of the seizure focus by both SPM and visual analyses were
compared with each patient’s temporal lobe resection site and with that patient’s postsurgical outcome. A good post-surgical outcome was defined as > 90% reduction in seizure
frequency six months after operation.
SPM analysis predicted the surgical excision site in 32/36 patients (89%); visual
analysis also correctly lateralized the temporal lobe resection site for 32/36 patients (89%).
The SPM and visual analyses were concordant in 30/36 (83%) cases; both provided a false
negative result in one cases. Of the 36 TLE patients, 31 had a successful surgical outcome
with > 90% reduction in seizure frequency six months after surgery. SPM analysis
identified the temporal lobe seizure focus in 28/31 of these patients (90%). Visual analysis

identified 29/31 (94%). Of the 5 patients with poor surgical outcome, SPM analysis
showed significant contralateral frontotemporal hypometabolism in 3 cases, and contra¬
lateral perihippocampal localization in 2 cases.
We conclude that SPM analysis of 18FDG PET images is useful for the localization
of temporal lobe seizure foci in clinical and research settings. SPM provides a more
objective and consistent means of image analysis for the evaluation of patients with
epilepsy, particularly for inexperienced observers. Our data suggests that SPM analysis
may also prove useful for the prediction of clinical outcome after temporal lobe resection.
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1
INTRODUCTION

Background - Clinical Epilepsy

Epilepsy is a term used to describe a diverse collection of disorders that affects
more than one percent of the population of the United States (1). These disorders are
characterized by episodic abnormal, paroxysmal electrical discharges within the brain that
are manifested as recurrent, spontaneous seizures (2). Seizures that begin within a localized
region of the brain cortex are termed “partial”. Generalized seizures diffusely involve both
cerebral hemispheres at the onset.
While a simple partial seizure does not impair the level of consciousness, a complex
partial seizure is associated with loss of contact (1). This impairment of consciousness can
be disabling for patients who suffer from recurrent and unpredictable complex partial
seizures, and can lead to poor school/work performance, and eventually an inability to
function independently (3). For some patients, medical treatment may be sufficient to
control seizure activity. However, many patients have intractable complex partial epilepsy
that cannot be controlled with reasonable doses of medication at tolerable levels of side
effects. These patients may benefit from surgical excision of the epileptogenic focus in the
brain, if this focus can be well localized.
Medically refractory patients comprise approximately 10-20% of the more than two
million people in this country with epilepsy (4). Of these, up to 50% have complex partial
seizures that are potentially localizable, and therefore amenable to surgical therapy. The
majority of complex partial seizures appear to arise from the temporal lobe (1). Following
temporal lobe surgery approximately 50-70% of patients with complex partial seizures
become seizure free, 10-30% are significantly improved, and the remaining 15-30% show
little or no improvement (5,6).
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Localization of Epileptic Foci

Selection of a patient with complex partial epilepsy for surgical therapy requires that
the abnormal electrical discharges within the brain be clearly and consistently localized to a
specific brain region. The presurgical evaluation of patients who are considered for
epilepsy surgery is completed in stages. During the first stage, non-invasive testing is
performed to screen patients and to plan additional testing for those patients who may be
surgical candidates. During the second and third stages, progressively more invasive
testing is performed for those patients whose Stage 1 localization is ambiguous. This
invasive testing includes intracranial electroencephalographic (EEG) monitoring (7).
The Stage 1 evaluation includes a thorough medical history and physical
examination, neuropsychological testing, ictal and interictal scalp EEG recordings, and a
series of imaging studies. The medical history may describe clinical features of the patient’s
epilepsy that are consistent with lateralization or localization of the seizure focus. The
neuropsychological tests are used to identify areas of intact and/or impaired cognitive
function that may be associated with an identified epilepsy syndrome (7).
Scalp ictal and interictal EEG recordings have classically been the mainstay of
seizure diagnosis and localization. The first epilepsy surgeries relied primarily on interictal
EEG identification of the seizure site. While the interictal scalp EEG remains an important
part of the diagnostic work-up of patients with epilepsy, the technique can reveal
ambiguous patterns and incorrect localization. Seizure foci may also remain undetected
(8,9). Video EEG recordings permit correlation of the patient’s ictal EEG pattern with
clinical behavior. This data can enhance the probability of accurately localizing the seizure
focus. However, the ictal EEG may falsely lateralize the seizure focus due to
muscle/movement artifact, rapid spread of abnormal electrical activity to bilateral or remote
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brain areas, or seizure onset in a deep brain region (7). In these cases, non-invasive
imaging studies may provide critical localizing information.
Radiographic and nuclear medicine studies can detect structural and functional
abnormalities in the brain that are correlated with epileptic seizure foci (2). Structural
imaging includes computed tomography (CT) and magnetic resonance imaging (MRI);
functional imaging includes single photon emission computed tomography (SPECT) and
positron emission tomography (PET). MRI and CT can identify small structural lesions
such as hamartomas, gliomas, and vascular malformations that may be the cause of seizure
activity. MRI may also define structural abnormalities within the temporal lobe and/or
hippocampus in patients with probable temporal lobe epilepsy. SPECT can detect regional
hypoperfusion in patients with lateralized epilepsy, with a sensitivity of 66% for temporal
and 60% for extratemporal lobe epilepsy. PET is used to identify focal hypometabolism in
the region of the seizure focus; a sensitivity of 84% has been reported for temporal lobe
epilepsy, 33% for extratemporal lobe epilepsy. Where available, interictal PET is preferred
for functional imaging of the patient with suspected temporal lobe epilepsy.
Stage 1 evaluation of the patient with potentially localizable epilepsy now includes a
conglomeration of clinical, EEG, and imaging tests. When the summed data, including
surface EEG and imaging tests, provide a concordant seizure site localization, some
epilepsy surgery centers now proceed directly to surgical resection, circumventing the need
for more invasive intracranial EEG recording with its attendant surgical risks of cerebral
infection and hemorrhage (10-12).

Positron Emission Tomography

PET imaging uses very small amounts of positron emitting radiopharmaceuticals to
identify and measure tissue function. Short-lived radioactive isotopes of elements such as
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carbon, oxygen, nitrogen, and fluorine are chemically “tagged” to compounds of
physiologic importance; these radiopharmaceuticals are then internally administered to the
patient. Organ specific uptake of the radiopharmaceutical is based upon the chemical
structure of the injected compound. For example, [1 ICjacetate, a marker of myocardial
oxidative metabolism, is targeted for and avidly extracted by heart muscle. A specialized
PET camera is then used to detect and record the annihilation photons that result when the
administered positrons interact with tissue electrons in the organ of interest (13,14). Images
of the distribution of the positron emitting radiopharmaceutical within tissue are generated
through a complex mathematical process known as filtered back projection. The resulting
image is a cross-section of the tissue or organ, with the intensity of each pixel element
proportional to the concentration of the radiopharmaceutical at that position in the body.
Patients with epilepsy have been successfully imaged with the PET
radiopharmaceutical [18F]fluoro-2-deoxyglucose (FDG), an analog of glucose (15). FDG,
like glucose, is actively extracted into brain tissue, and is phosphorylated by hexokinase in
the first step of the glycolytic pathway. Unlike glucose, FDG is not further metabolized and
is essentially trapped in tissue. Images of FDG distribution within the brain therefore reflect
regional cerebral glucose utilization, with the highest concentrations of radiopharmaceutical
found in areas of greatest metabolic activity.
PET images reveal reduced interictal cerebral glucose metabolism in patients with
epilepsy (15-18). This evidence is particularly strong for patients with complex partial
seizures of temporal lobe origin. A recent retrospective review of the literature showed that
asymmetrically decreased metabolic activity within the temporal lobe accurately localizes the
seizure focus in patients with complex partial epilepsy. The sensitivity of FDG PET for
temporal lobe epilepsy as compared to an EEG gold standard was 84%, with a specificity
of 86% (1).
Compared to a tissue pathology gold standard, the sensitivity of PET for temporal
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lobe epilepsy was 81%, with a specificity of only 22%. This lower specificity may
represent extension of PET hypometabolism beyond the pathology defined seizure site,
consistent with a larger area of functional disturbance within the brain than would be
expected on the basis of structural changes alone. Analysis of the distribution of
radiolabeled FDG within the temporal lobe has had varying results; recently, Hajek etal
related tissue pathology to FDG distribution within the temporal lobe (1). Patients with
medial temporal lobe epilepsy showed diffuse temporal lobe hypometabolism; patients with
temporal neocortical epilepsy had more limited hypometabolism within the lateral temporal
cortex.
Several studies have related PET findings to surgical outcome in epilepsy. PET
hypometabolism predicts a favorable clinical outcome for 71-96% of patients (20-23). It
should be noted, however, that published studies lack consistency in the method of PET
data analysis and in the definition of a “good” surgical outcome after epilepsy surgery.
Table 1 summarizes these studies.

PET Image Analysis

PET image analysis can be performed by qualitative or quantitative means.
Qualitative analysis consists of the identification of regions of hypometabolism through
visual interpretation. In patients with suspected temporal lobe epilepsy, FDG PET images
of the temporal lobes are carefully examined for global and/or regional asymmetries in
radiopharmaceutical uptake. Left is compared to right in order to detect areas of
abnormality. A rough measure of the severity of hypometabolism can be made by judging
the degree of asymmetry between the abnormal temporal lobe and the presumably normal
contralateral side.
Visual qualitative analysis is necessarily subjective and requires the observer to

5a

No. of
Patients

No. of
Good
Outcome

No. of
Poor
Outcome

Definition of Good Surgical Outcome

Heinz et al (20)

24

17 (71%)

7 (29%)

> 90% reduction, < 10 seizures/year

Manno et al (21)

35

29 (83%)

6(17%)

seizure free

Radtke et al (22)

25

24 (96%)

1 (4%)

> 75% reduction of seizures

Theodore et al (23)

42

35 (83%)

7(27%)

seizure free

Studv

Table 1

Summary of studies comparing PET imaging with surgical outcome for patients
with temporal lobe hypometabolism and subsequent temporal lobectomy.
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pinpoint differences in image intensity in order to identify a region of abnormality. The
observer is also asked to relate areas of abnormality to regional brain anatomy. These tasks
may prove difficult for an inexperienced reader (24). Qualitative interpretation of FDG PET
can also be complicated by a bilateral temporal or diffuse reduction in metabolism that
precludes identification of a metabolic asymmetry. For example, global hypometabolism
that results from use of antiepileptic drugs (AED) may mask localized epileptic foci (25).
PET images of regional cerebral glucose metabolism can also be quantified.
Quantification can lend objectivity to image analysis that is not possible through visual
interpretation. Quantification requires a computer based region of interest analysis to
determine the concentration of radioactivity within user defined regions of interest in the
temporal lobe and whole brain. Radioactivity concentration can be described as: 1) an
absolute measurement, with the local cerebral glucose metabolic rate given in units of
mg/100 gm/min ; 2) a ratio of activity in the region of interest to activity in a normal area of
metabolism. The “normal” area might be the homologous contralateral brain cortex, or an
area such as the cerebellum that is presumably unaffected by the temporal lobe epilepsy
process.
Absolute quantification of the cerebral glucose metabolic rate can be performed
using a model developed by Sokoloff et al and is based upon knowledge of the arterial
input function into the brain and plasma glucose concentration (26). Calculation of an
absolute metabolic rate therefore requires serial blood samples from the patient to determine
the amount and time course of delivery of injected radiopharmaceutical to the brain, as well
as the plasma glucose concentration. Problems with absolute value analysis are the
necessary complexity of the analysis, the requirement for frequent invasive blood draws,
and possible confounding of the results by AED use (27,28). Quantitative analysis is also
plagued by compromises between sensitivity and specificity when determining appropriate
threshold values for normality (21,29). In addition, semi-quantitative ratio analysis is
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problematic since bilateral and/or global hypometabolism can deter attempts to identify a
localized focus of abnormality.
The purpose of this research project was to evaluate the utility of a new tool,
statistical parametric mapping analysis (SPM) of FDG PET, for the detection of seizure foci
in patients with complex partial epilepsy. SPM refers to the construction of statistical maps
of change significance, in which the patient’s images of cerebral glucose metabolism are
compared on a voxel by voxel basis to images from a group of healthy controls such that
areas of significant difference are highlighted. SPM has several theoretical advantages over
current methods for FDG PET brain image analysis. These include substantial elimination
of subjectivity in image analysis, more precise anatomic localization of functional
abnormalities, and avoidance of blood sampling. Additionally, bilateral and global changes
in metabolism are not masked as each patient can be compared to a normal healthy control
population.

Statistical Parametric Mapping

Statistical parametric mapping (SPM) has been used to evaluate PET images of
regional cerebral blood flow and metabolism and to identify significant changes from the
patient’s own baseline or from healthy control subjects (30-32). Applications for SPM have
been reported in PET studies of memory, sensory and motor activation, Alzheimer's
disease, Parkinson's disease, and amyotrophic lateral sclerosis (33-37). Based on these
reports, we believed that SPM analysis would prove useful for the detection of abnormal
temporal lobe metabolism.
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STATEMENT OF PURPOSE

The primary objective of this study was to compare the utility of statistical
parametric mapping (SPM) analysis to visual interpretation of FDG PET brain images for
the detection of seizure foci in patients with complex partial epilepsy. A secondary objective
was to determine the relationship between the SPM defined seizure focus and clinical
seizure outcome following epilepsy surgery.
We hypothesized that SPM analysis would prove more sensitive than visual
analysis for the detection of seizure foci and for the prediction of post-operative seizure
outcome in patients with complex partial epilepsy, based on the greater objectivity and
greater potential sensitivity of the statistical method.
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METHODS

Patient Selection

From January 1992 to June 1996, 156 patients with complex partial seizures of
presumed temporal lobe origin were referred to the Yale-VA PET Center for imaging of
regional cerebral glucose metabolism. Of this number, 80 patients subsequently underwent
temporal lobectomy and had at least six months of clinical follow-up data available at the
time of this study. From this group of subjects, 28 patients with known neoplastic or
vascular lesions within the temporal lobe as identified from pathology, biopsy, or MRI
reports were excluded. Image data could be retrieved for 36 of the remaining 52 patients.
These 36 PET image data sets were retrospectively reanalyzed, and the results compared
with each patient’s surgical resection site and post-surgical outcome.
There were 18 men and 18 women in the group of epilepsy patients. Mean patient
age at the time of PET imaging was 35.1 yrs. (range 9.2 - 55.3 yrs.). The mean duration of
illness was 28.7 yrs. (range 4.2 - 51.0 yrs.). Average age of seizure onset was 6.4 yrs.
(range 0-36 yrs.).
Image data from 8 healthy control subjects were also retrospectively reviewed and
reanalyzed. The healthy control subjects were eight men with a mean age of 44 (range 25 60). Healthy subjects had no history of significant medical disease, and specifically no
neurologic or psychiatric complaints. Each control subject provided a complete medical
history, underwent a physical examination, and had normal serum chemistry and
hematology tests prior to inclusion in the normal database. These patient studies were
approved by the V.A. Institutional Review Board protocol under the direction of Dr.
Douglas Bremner.
Presurgical evaluation for all epilepsy patients included ictal and interictal surface
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EEG and PET scan. In addition, intracranial EEG, MRI, ictal and interictal SPECT,
neuropsychiatric testing, and cerebral angiography may have been performed during the
course of the staged pre-surgical evaluation.
All 36 epilepsy patients underwent temporal lobectomy. The standard surgery was
an anteromedial temporal lobectomy with hippocampectomy. The extent of tissue resection
differed between patients, and was based on the results of pre-surgical testing. There were
a total of 24 left sided resections and 12 right sided.

PET Imaging

PET studies were performed on a Posicam 6.5 whole body camera (Positron
Corporation, Houston, Texas). Patients were positioned in the camera gantry with the
orbital meatal line oriented to the x-y plane. An intravenous injection of 10 mCi of 18-FDG
was then administered. During radiopharmaceutical injection the patient’s eyes remained
open and the camera room was dimly lit. Extraneous noise was minimized, and soft
background music was played during and after dose administration. Forty-five minutes
were allowed for clearance of FDG from the blood pool and uptake into brain. Image data
were subsequently acquired until approximately 60 million positron annihilation events
were recorded (approximately 20 min.). Two overlapping brain scans were obtained for
each patient in order to maximize the likelihood of obtaining high quality images of the
temporal lobes.
The axial field of view of the camera was 11.5 cm. Twenty-one image slices were
acquired, separated by 5.125 mm with an axial resolution of 11 mm. In plane resolution
was 5.7 mm (full width at half maximum). A theoretical attenuation correction was applied
to the acquired image data; a uniform attenuation coefficient of 0.096 cm'1 was applied.
Transverse image reconstruction was performed using filtered backprojection with a
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Butterworth 8 filter using a cutoff of 0.04, cutoff fraction of 0.306, and filter order of
10.0. Images were reconstructed in a 256 x 256 matrix with a pixel size of 1.7 mm.
Reoriented tomograms were displayed in the axial, coronal, and sagittal planes. A graded
color display was normalized to the area of maximum activity. Each change (gradation) in
color represented a 5% difference in normalized intensity.

PET Visual Analysis

PET brain images were visually interpreted by an experienced nuclear medicine
physician (H.M.D.) who was blinded to the patients’ clinical information, except the
knowledge that patients had a surgical epilepsy procedure. Visual analysis involved careful
review of each patient’s PET scan with comparison of relative FDG uptake within
homologous brain regions utilizing the graded color display. Areas of relative
hypometabolism were recorded on data sheets (see Appendix). For each abnormal region
the affected lobe/structure (temporal, frontal, parietal, occipital, cerebellum, thalamus, basal
ganglia) was noted, and the distribution of hypometabolism within that region (medial
/lateral, anterior/posterior, and superior/inferior) was defined. An asymmetry index was
generated for each abnormal brain region by comparing FDG uptake within the
hypometabolic lobe to uptake within the contralateral homologous brain tissue. The
asymmetry index was based upon the graded color image display scale. Differences in
uptake between the temporal lobes, for example, was recorded as: None (< 5% asymmetry
in uptake on the graded color scale). Minimal (5-10% asymmetry). Mild (10-15%
asymmetry), Moderate (15-20% asymmetry), or Severe (>20% asymmetry). When both
homologous brain regions appeared hypometabolic, an additional measure of uptake,
termed the “absolute index”, was generated by comparing activity within the regions of
abnormality to uptake within a presumably normal area of brain metabolism (typically the
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cerebellum). For each patient’s PET scan an overall reading was generated, with the area of
most significant hypometabolism defined as the likely seizure site.

PET SPM Analysis

Image data from all 36 patients with temporal lobe epilepsy and from the 8 healthy
control subjects were transferred to a SUN SPARC station 10 for SPM analysis. The
image data were analyzed using SPM95 software written for Matlab version 4.2.
Preprocessing of the data prior to statistical analysis was required. All scans were
transformed into Talairach space based on an automated computer definition of the anteriorposterior commissural line. This procedure ensured that functional brain abnormalities
could consistently be mapped to brain anatomy using the Talairach stereotaxic brain atlas.
Data sets were then globally normalized to correct for individual differences in the injected
dose of radioactivity, and smoothed. A statistical analysis of the data sets was performed.
Each patient’s PET scan was compared against data sets from the 8 healthy control subjects
on a voxel by voxel basis with computation of the t statistic. A statistical map representing
change significance between the patient’s PET scan and the normal database was generated
and thresholded at p < 0.001. Voxels with z scores > 3.0 (p < 0.001) were highlighted on
coronal, axial, and sagittal image displays. An experienced nuclear medicine physician
(H.M.D.) then visually analyzed the SPM maps to describe areas of regional
hypometabolism. The likely seizure site was defined as that localized brain region
demonstrating the most significant hypometabolism on SPM map. Where present,
extension of hypometabolism to include remote areas of brain cortex was described in the
SPM interpretation.
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Statistical Analysis for Localization and Surgical Outcome

Both the visual and SPM analyses of the PET data were retrospectively compared to
each patient’s chosen surgical site. The sensitivity of both visual and SPM analyses for
localization of the seizure site as defined by the surgery gold standard was calculated. The
PET analyses were considered to have provided a true positive localization if the major
identified focus of hypometabolism matched the surgical site, regardless of the presence of
additional, less significant areas of hypometabolism. When homologous brain regions were
bilaterally abnormal, the more hypometabolic side was labeled as the likely seizure focus.
Both visual and SPM PET data analyses were also compared with the patients’
post-surgical outcome data. For this purpose, a good surgical outcome was defined as a
greater than 90% reduction in seizure frequency 6 months after operation. Thirty-two of the
36 patients were evaluated at > 1 year after surgery. A poor surgical outcome was
considered less than a 90% reduction in seizure activity. For both visual PET interpretation
and SPM analysis positive predictive values were calculated. The sensitivities and positive
predictive values of the PET analyses for surgical outcome were compared using the
McNemar test.

Pathology Analysis

For 33/36 epilepsy patients the results of histopathologic examination of the
resected brain tissue were available. Abnormal findings within the resected temporal lobe
were recorded and variably classified as hippocampal sclerosis, non-hippocampal gliosis,
congenital abnormality (e.g. heterotopia), or other. Histopathology findings were then
compared with the regional cerebral distribution of hypometabolism defined by visual and
statistical analyses of the PET image data.
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RESULTS

PET Imaging Results

Results of the visual analysis of the FDG PET scans are provided in Table 2.
Temporal lobe hypometabolism was identified in 33 of 36 patients. One patient had
regional hypometabolism limited to the frontal lobe. Two patients had PET scans that were
interpreted as showing no focal abnormality. Relative temporal hypometabolism was
visually graded as follows: a severe asymmetry was found in 12 cases, moderate
asymmetry in 8, mild asymmetry in 11, and minimal in 2 cases. Extratemporal ipsilateral
extension of hypometabolism was identified in 21 patients for a total of 29 extratemporal
sites. Extratemporal hypometabolism was described as follows: a frontal lobe abnormality
was found in 13 patients, parietal lobe in 8, occipital lobe in 5, thalamic hypometabolism
was noted in 1, basal ganglia abnormality in 2 cases. Bilateral temporal lobe
hypometabolism was present in 5 patients.
Table 2 describes the results of the SPM analysis of the FDG PET data. Temporal
lobe hypometabolism was present in 35/36 patients. Of these, 21 regions of
hypometabolism were classified as frontotemporal and 3 as temporooccipital. One patient
had a discrete occipital lobe abnormality. There were no normal scans. Bilateral extension
of hypometabolism was found in 29 patients. Visual analysis of the SPM maps graded the
extratemporal extension of hypometabolism as follows: severe extension in 8 cases,
moderate in 6, mild in 7, and minimal in 7 cases. The location of the extensions were as
follows: frontotemporal in 20 cases, frontal in 4, temporal in 3, and temporooccipital in 2
cases.
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Visual Analysis
Surgical
Outcome
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Poor
Poor
Poor
Poor
Poor

Surgical
Site
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Right
Right
Right
Right
Right
Right
Riqht
Riqht
Riqht
Riqht
Left
Left
Left
Right
Riqht

Table 2.

Side
-

B (L>R)
B (L>R)
B (L>R)
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
B (L>R)
Right
Right
Right
Right
Right
Right
Right
Right
Right
B (L>R)
Left
Left
-

Riqht

Location
normal
temp
temp + front
temp + front
temp
temp
temp
temp
temp
temp
temp
temp + front
temp + front
temp + front
temp + front
temp + front + parietal
temp + occip + BG
temp + parietal
temp + parietal
temp + parietal + occip
temp + parietal + occip + front
temp + front + thalamus
temp
temp
temp
temp + front
temp + front
temp + front + occip
temp + front + parietal
temp + parietal
temp + parietal
temp
frontal + BG
temp
normal
temp + occip

SPM Analysis
Major Reqion
L frontotemp
L temp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L temp
L frontotemp
L frontotemp
L frontotemp
L frontotemp
L temp
L temporooccip
L frontotemp
L temp
L frontotemp
L temp
L temp
R frontotemp
R temp
R temp
L frontotemp
L occip
R frontotemp
R temporooccip
L temp
R temp
L temp
L frontotemp
L frontotemp
R temporooccip
R frontotemp

Bilateral Extension
severe R frontotemp/perihipp
mild R front
mild R frontotemp
severe R frontotemp
min R front
min R frontotemp
mod R frontotemp
mod R frontotemp/perihipp
none
severe R frontotemp
none
mild R temp
mod R frontotemp
none
severe R frontotemp/perihipp
min R front
min R frontotemp
min R front
none
mod R temp
min R frontotemp
mild R frontotemp
severe L frontotemp
none
none
mild R frontotemp
none
mod L frontotemp
mod L tempoccip
severe R frontotemp
min L frontotemp
mild R temp/perihipp
mild R frontotemp/perihipp
severe R frontotemp
severe L tempoccip
severe L frontotemp

Pt.
No.
1
2
3
4
5
6
7
8
9
10
1 1
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36

Results of surgical site, surgical outcome, visual PET analysis, and SPM PET
analysis. For surgical outcome, "good" represents > 90% seizure reduction at a
minimum of 6 months follow-up; "poor" represents < 90% seizure reduction.
Surgical site lists the side of the temporal lobectomy. Visual analysis lists side
and location of hypometabolism. SPM Analysis lists side and location of the
major region of hypometabolism along with significant bilateral extensions and
degree. PET analyses which do not agree with surgical site are highlighted.
Abbreviations: B = bilateral; L = left; R = right; temp = temporal lobe; parietal =
parietal lobe; occip = occipital lobe; front = frontal lobe; min = minimal; mod =
moderate; perihipp = perihippocampal region.
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Localization of Epileptic Foci Analysis

Visual analysis was concordant with the surgical site in 32/36 (89%) cases. Two
scans were normal (Patients 1 and 35). One patient was incorrectly lateralized (Patient 22).
One patient was localized to the wrong lobe of the brain (Patient 33).
SPM analysis was also concordant with the surgical site in 32/36 (89%) cases.
Four patients were incorrectly lateralized (Patients 22, 26, 27, 33). Patient 33 was
incorrectly lateralized by both visual and SPM analyses. The SPM and visual analyses were
concordant in 30/36 (83%). There was no difference between the sensitivities of visual vs.
SPM analyses for detection of the temporal lobe resection site.

Surgical Outcome Analysis

Favorable clinical outcomes were reported for 31 of 36 (86%) patients. Visual
analysis identified 29/31 (94%), while SPM analysis identified 28/31 (90%) cases. Figures
1 and 2 show clinical PET and SPM image data from Patient 16 with a good surgical
outcome. There was no statistically significant difference between the positive predictive
values of PET visual and SPM analyses for favorable post-surgical outcome.
Five patients had poor surgical outcomes, with frequent recurrent seizures. One of
these patients had bilateral temporal lobe hypometabolism by visual analysis. SPM revealed
severe contralateral temporal hypometabolism in 3 cases (e.g. Patient 34 in Figure 3) and
contralateral perihippocampal hypometabolism in 2 cases (e.g. Patient 32 in Figure 4).
Of the five patients considered to have bilateral temporal hypometabolism on visual
analysis, one had a poor clinical outcome. Of the 29 patients with bilateral temporal
abnormalities on SPM analysis, 5 had a poor outcome. Of patients with severe bilateral
extension of hypometabolism on SPM, 3/9 showed no improvement after epilepsy surgery.
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Figure 1. PET image for visual analysis from Patient 16 with a good surgical outcome.
Two coronal slices (A, B) and two transaxial slices (C, D) are shown. Left
temporal lobe hypometabolism is evident in B and D. There is also frontal (A)
and parietal (C) hypometabolism.

16b

Figure 2. PET image for SPM analysis from Patient 16 with a good surgical outcome. The
surgery was located on the left side, and the pathology report revealed
hippocampal sclerosis. Sagittal, coronal, and transaxial views are shown. On the
coronal view, the left side of the patient is displayed on the left side of the image.
Left frontotemporal hypometabolism is present with a pixel size of 6693 and a Zscore of 5.06.
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Figure 3. PET image for SPM analysis from Patient 34 with a poor surgical outcome. The
surgery was located on the left side, and the pathology report revealed
hippocampal sclerosis. Sagittal, coronal, and transaxial views are shown. On the
coronal view, the left side of the patient is displayed on the left side of the image.
Bilateral (left > right) frontotemporal is present with a pixel size of 3305 and a Zscore of 4.87.
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Figure 4. PET image for SPM analysis from Patient 32 with a poor surgical outcome. The
surgery was located on the left side, and the pathology report revealed
hippocampal sclerosis and non-hippocampal gliosis. Sagittal, coronal, and
transaxial views are shown. On the coronal view, the left side of the patient is
displayed on the left side of the image. Left frontotemporal hypometabolism is
present with a pixel size of 6693 and a Z-score of 5.06. Contralateral right
perihippocampal hypometabolism is also present with a pixel size of 140 and a
Z-score of 4.36.
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Pathology and Temporal Lobe Hypometabolism

Histopathologic correlation was available for 33 patients. Results are summarized in
Table 3. Microscopic examination of resected temporal lobe tissue revealed the following:
hippocampal sclerosis in 18 patients, hippocampal sclerosis and non-hippocampal gliosis in
7 cases, non-hippocampal gliosis in 5 cases, hippocampal sclerosis and heterotopia in 1
case, hippocampal hemorrhage in 1 case, and heterotopia in 1 case.
Visual PET image analysis revealed that 23/25 (92%) patients with hippocampal
sclerosis or hippocampal sclerosis and non-hippocampal gliosis demonstrated ipsilateral
temporal lobe hypometabolism that included the medial, anterior, and inferior regions. One
scan was normal. One scan contained a defect in the frontal lobe. More detailed regional
analysis showed medial > lateral hypometabolism in 20/25, anterior > posterior in 22/25,
inferior > superior in 23/25 patients. Ipsilateral frontal extension of the hypometabolic zone
was present in 8/25, parietal extension in 4/25, and occipital extension in 3/25. By SPM
analysis, 24/25 cases had ipsilateral temporal lobe hypometabolism.
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Patholoqy
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, qliosis
hipp sclerosis, heterotopia
gliosis
gliosis
qliosis
gliosis
gliosis
heterotopia
none
none
none
old hemorrhage in hipp

Table 3.

Medial vs. Lateral
medial>lateral
medial>lateral
medial>lateral
medial>lateral
medial>lateral
medial>lateral
mediaklateral
mediaklateral
medialdateral
medialdateral
medialdateral
medialdateral
medialdateral
medialdateral
mediaklateral
medialdateral
mediaklateral
normal
mediaklateral
mediaklateral
mediaklateral
mediaklateral
mediaklateral
medial
no temporal defect
mediaklateral
mediaklateral
mediaklateral
mediaklateral
mediaklateral
normal
lateral
mediaklateral
mediaklateral
mediaklateral
mediaklateral

Regional Temporal Lobe Hypometabolism
Inferior vs. Superior
Anterior vs. Posterior
anterior>posterior
inferior>superior
anterior>posterior
inferior>superior
anterior>posterior
inferior>superior
anterior=posterior
inferior>superior
anterior=posterior
inferior>superior
anterior
inferior
anterior>posterior
inferior>superior
anterior>posterior
inferior>superior
anterior>posterior
inferior>superior
anterior>posterior
inferior>superior
anterior=posterior
inferior>superior
anterior=posterior
inferior>superior
anterior=posterior
inferior=superior
anterior
inferior>superior
anterior>posterior
inferior>superior
anterior=posterior
inferior>superior
anterior=posterior
inferior>superior
anterior>posterior
anterior=posterior
anterior
anterior
posterior
anterior

inferior>superior
inferior>superior
inferior>superior
inferior
inferior
inferior

anterior> posterior
anterior>posterior
anterior>posterior
anterior=posterior
anterior=posterior

inferior>superior
inferior>superior
inferior
inferior=superior
inferior=superior

anterior=posterior
anterior>posterior
anterior
anterior>posterior
anterior>posterior

inferior>superior
inferior>superior
inferior
inferior>superior
inferior>superior

Pt.
No.
18
31
2
1 1
9
4
5
20
7
12
34
16
13
15
24
23
14
1
32
17
22
6
28
10
33
21
25
26
30
29
35
36
8
27
3
19

Results of pathology and regional location of temporal lobe hypometabolism.
Abbreviations: hipp = hippocampus; gliosis = non-hippocampal gliosis.
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DISCUSSION

SPM As a Useful Analytic Tool for Epilepsy

PET images of regional cerebral metabolism have proven useful for the localization
of seizure foci in patients with complex partial epilepsy. These images are most commonly
interpreted through visual analysis. The reader is asked to compare homologous brain
regions in order to identify areas of relative hypometabolism. The reader is then asked to
map these functional abnormalities to specific anatomic structures/areas within the brain.
These areas are then considered as potential sources for that patient’s seizure activity. Both
tasks can be difficult for the inexperienced observer, leading to interpretive error. A more
objective and consistent means of image analysis would be useful for the evaluation of
patients with epilepsy.
A number of quantitative/semi-quantitative methods for PET data analysis have
been described. These include absolute quantification of regional cerebral glucose
metabolism and ratio based region of interest analysis. Absolute quantification requires
invasive blood sampling during acquisition of the PET data, as well as complex
mathematical manipulation of the acquired data. Ratio based analyses are semi-quantitative
and are not useful for the detection of bilateral or diffuse abnormalities.
We have proposed using a new tool, statistical parametric mapping (SPM), for the
objective analysis of FDG PET brain images in epilepsy. SPM is a powerful statistical
method of localizing differences in regional cerebral metabolism. The patient’s image data
are compared on a voxel by voxel basis to data from a group of normal, healthy control
subjects using the Student’s t test. The results are displayed as a statistical map that
represents images of change significance. These maps are thresholded such that voxels
reaching a specified level of significance are highlighted. The theoretical advantages of
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SPM include its objectivity, precise anatomic localization of functional abnormalities,
avoidance of blood sampling, and the ready identification of diffuse and bilateral
abnormalities.
In this paper, we compared SPM to visual analysis of PET brain scans for the
detection of seizure foci and prediction of post-surgical outcome in complex partial
epilepsy. We found that SPM analysis identified the seizure focus, as defined by the
eventual surgical resection site, in 32/36 (89%) patients that were evaluated. The SPM
defined seizure site correlated with the surgical site in 28/31 (90%) patients who had good
outcomes. These results are in agreement with the outcome of our own visual PET analysis
and with published literature values that describe the utility of PET for seizure site
identification (2,20-23). We conclude that SPM analysis is useful for the evaluation of PET
data in epilepsy, and may provide an objective and sensitive means of seizure site
identification.
To the best of our knowledge, this is the first report of the use of SPM for FDG
PET analysis in epilepsy. There has been one prior report, however, on the use of
“statistical parametric imaging” (28). In this paper, the authors performed a statistical
analysis that compared temporal lobe uptake of radiopharmaceutical to the patient’s own
mean global cerebral metabolism. Image data from 17 patients were retrospectively
reviewed by the authors; seizure foci for 16/17 patients were correctly lateralized using the
statistical method. Unlike our study, patient data was not compared to a normal database of
FDG images. Each patient served as his/her own control. It is therefore possible that
regional hypometabolism was underestimated, and that areas of abnormality were not
detected due to some level of global cerebral hypometabolism. Study of larger groups of
patients would be necessary to determine whether our SPM method of data analysis is more
sensitive than statistical parametric imaging for the detection of localized seizure foci.
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Implications of Bilaterality and Extratemporal Extensions

It is interesting to note that SPM analysis identified significant regions of
hypometabolism both adjacent to and remote from the primary temporal focus of
abnormality. When visual and SPM analyses were compared, it was clear that SPM more
consistently identified extratemporal lobe extension of abnormal hypometabolism. This
extended area most commonly involved the frontal lobe, but on occasion included the
parietal or occipital cortex, and sometimes implicated the contralateral temporal lobe and
hippocampus.
Some published reports suggest that extratemporal lobe foci of hypometabolism
connote a poor prognosis (22,38), while other reports show no discernable difference
(23,39) in patient outcome. Our own results are preliminary, and not conclusive in this
regard. We found that 29/36 patients had extratemporal lobe extension of hypometabolism
on SPM analysis. This extratemporal extension was subjectively graded as “severe” in 9
cases. When these 9 cases were reviewed, it was determined that 6 of the 31 patients with
good post-surgical outcomes had diffuse hypometabolism on SPM analysis, while 3 of the
5 patients with poor post-surgical outcomes had severe extratemporal extension of
hypometabolism. Unfortunately, the number of patients with poor surgical outcome in our
study, as well as in the other studies referenced above, is too small to draw any definite
conclusions regarding a correlation between extratemporal lobe hypometabolism and
prognosis in complex partial epilepsy.
The pathophysiologic significance of extratemporal/bilateral hypometabolism on
PET images of temporal lobe epilepsy is not clear. This scintigraphic finding may reflect
deafferentation, with defective neuronal connections and projections between the
hippocampus and temporal, extratemporal, and contralateral sites (40). These connections
may be very fine; their detection might be facilitated by the use of SPM rather than the more
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gross inspections made through visual analysis. Alternatively, extratemporal lobe
hypometabolism may suggest a widespread ultrastructural brain abnormality that could
have resulted from a congenital defect during critical periods of brain development (41).

Comparison of Regional Temporal Hypometabolism to Histopathology

Hippocampal sclerosis is a histopathologic diagnosis associated with temporal lobe
epilepsy (41). Hippocampal sclerosis can be detected on MRI (42,43), and has been
associated with PET temporal lobe hypometabolism (44). In our study, we subdivided the
temporal lobe into medial, lateral, anterior, posterior, inferior, and superior regions during
visual analysis. We found that 23/25 (92%) scans of patients with hippocampal sclerosis (±
non-hippocampal gliosis) had inferior anteromedial temporal hypometabolism. This
suggests that PET imaging may provide important non-invasive evidence for the presence
of hippocampal sclerosis.

Limitations of the Study

This study was limited by the small size of the epilepsy patient, and especially of
the healthy control, study groups. It is possible that comparison of patient data to a larger,
more diverse population of healthy control subjects could reveal more limited areas of PET
brain hypometabolism, and less extensive extratemporal extension of metabolic
abnormality.
This study was also limited by the absence of a literature based definition for the
range of SPM significance. It is still unclear whether SPM readings should be based solely
on z score, on the number of significant voxels, or on a combination of both criteria. In this
study, the area of greatest z score significance was selected as the most likely seizure focus.
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CONCLUSIONS

In this study, SPM analysis of FDG PET brain images was as sensitive as visual
analysis for the localization of seizure foci and for the prediction of favorable clinical
outcome after epilepsy surgery. We would encourage the development of SPM as a
supplement or alternative to visual analysis due to the ease of use and reproducibility of
inteipretation. SPM is also useful for quantitative research analysis which can be compared
to clinical data, imaging modalities such as SPECT and MRI, and pathology data such as
hippocampal cell loss.
SPM analysis revealed significant extension of PET hypometabolism to
extratemporal brain regions. This finding may reflect the connections and projections of
neurons from the hippocampus to other temporal lobe, extratemporal lobe, and contralateral
sites. Alternatively, this widespread functional abnormality may result from developmental
brain damage that includes extratemporal brain regions.
Future directions for SPM would include creation of a large normal database of
healthy subjects, and creation of more rigid interpretation criteria regarding the size and
level of z score significance required to pinpoint the seizure focus. Continued investigation
of the utility of SPM for the localization of both temporal lobe and extratemporal lobe
epilepsies should be pursued. As more data is acquired, patterns may emerge that will
enhance the likelihood of image based detection of epileptic foci.
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APPENDIX

PET - Epilepsy Data Form
ID Label:

Name:
Date of PET:
ID Number:

1
2
Overall 1
Category 2
3
4
5
6
Reader

=
=
=
=
=
=
=
=

Dr. Holley Dey
Dr. Raiesh Krishnamurthv
normal
temporal lobe only
temporal with frontal extension
temporal with parietal extension
temporal with occipital extension
temporal with other extension

13 = other (describe below)
Bilateral 1 = Yes

Notes

7
8
9
1 0
1 1
1 2

=
=
=
=
=
=

frontal lobe only
frontal lobe with extension
parietal lobe only
parietal lobe with extension
occipital lobe only
occipital lobe with extension
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REGION 2

REGION 1

Lobe

1
2
3
4

=
=
=
=

3 = med. + lat.
= lat. > med.

Area 1

1
4

= med. 2 =
= med. > lat.

lat.
5

3 = med. + lat.
= lat. > med.

= ant. 2 = post.
= ant. > post.
5

3 = ant. +post.
= post. > ant.

Area 2

1
4

= ant. 2 - post.
= ant. > post.
5

3 = ant. +post.
= post. > ant.

1
4

= sup.
2 =
= sup. > inf.

inf.
5

3 = sup. + inf.
= inf. > sup.

Area 3

1
4

= sup.
2 =
= sup. > inf.

inf.
5

3 = sup. + inf.
= inf. > sup.

Sp. Type

1

= focal

diffuse/patchy

Sp. Type

1

= focal

diffuse/patchy

Side

1
3
4
5

=
=
=
=

Side

1
3
4
5

=
=
=
=

Lobe

1
2
3
4

=
=
=
=

Area 1

1
4

= med. 2 =
= med. > lat.

lat.
5

Area 2

1
4

Area 3

Metabol.
Asym.
Index

1

1
2
3
4

temporal
frontal
parietal
occipital

5 =
6 =
7 =

2 =

left
2
bilateral
bilateral
bilateral

= right
left = right
left > right
right > left

= hypomet.
Absolute
Index

5
6

cerebellar
thalamus
basal ganglia

2

= hypermet.

1
2
3
4

=
=
=
=

< 5% (none)
5-10%
(minimal)
10-15%
(mild)
15-20% (moderate)

5
6

= > 20% (severe)
= post op (missing)

= right
left = right
left > right
right > left

= hypomet.
Absolute
Index

1
2
3
4
5
6

2
=
=
=
=
=
=

= hypermet.

< 5% (none)
5-10%
(minimal)
10-15%
(mild)
15-20% (moderate)
> 20% (severe)
post op (missing)

=
=
=
=
=

3 = med. + lat.
= lat. > med.

Area 1

1
4

3 = ant. +post.
= post. > ant.

Area 2

1
4

Area 3

1
4

Sp. Type

1

1
3
4
5

= sup.
2 = inf. 3 = sup. + inf.
= sup. > inf.
5 = inf. > sup.
= focal 2 = diffuse/patchy
= left
2 = right
= bilateral left = right
= bilateral left > right
= bilateral right > left

Side

1
3
4
5

= sup.
2 = inf. 3 = sup. + inf.
= sup. > inf.
5 = inf. > sup.
= focal 2 = diffuse/patchy
= left
2 - right
= bilateral left = right
= bilateral left > right
= bilateral right > left

1

= hypomet.

1

=

Area 1

1
4

Area 2

1
4

Area 3

1
4

Sp. Type

1

Side

5 =
6 =
7 =

temporal
frontal
parietal
occipital

med. 2 = lat.
= med. > lat.
5
= ant. 2 == post.
= ant. > post.
5

Absolute
Index

1
2
3
4
5
6

2
=
=
=
=
=
=

cerebellar
thalamus
basal ganglia

= temporal
= frontal
= parietal
= occipital
= med. 2 =

1
2
3
4

1
2
3
4

1
2
3
4
5
6

2 =

left
2
bilateral
bilateral
bilateral

cerebellar
thalamus
basal ganglia

Lobe

Lobe

Metabol .

1
1
2
3
4
5
6

5 =
6 =
7 =

REGION 4

REGION 3

Asym.
Index

Metabol.
Asym.
Index

temporal
frontal
parietal
occipital

= hypermet.

< 5% (none)
5-10%
(minimal)
10-15%
(mild)
15-20% (moderate)
> 20% (severe)
post op (missing)

Metabol .
Asym.
Index

1
2
3
4
5
6

5 =
6 =
7 =

lat.
= med. > la
5
= ant. 2 = post.
= ant. > post.
5

hypomet.

Absolute
Index

1
2
3
4
5
6

2
=
=
=
=
=

cerebellar
thalamus
basal ganglia

3 = med. + lat.
= lat. > med.
3 = ant. +post.
= post. > ant.

= hypermet.

< 5% (none)
5-10%
(minimal)
10-15%
(mild)
15-20% (moderate)
> 20% (severe)
post op (missing)
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